Big move! Two billion M&A and restructuring funds in Shanghai have come to target the chip and pharmaceutical industries.For the biomedical industry, Bu Rixin told the reporter of science and technology innovation board Daily that the investment cycle of biomedicine is generally long, and it needs to go through multiple stages from research and development to listing."The government's participation in M&A fund investment does not mean that the government will dominate the M&A business, but encourage market-oriented institutions and chain owners to lead the M&A business through the above-mentioned M&A fund or parent fund support." Bu Rixin believes.
Big move! Shanghai's 10 billion integrated circuit design industry M&A fund has come.A 10 billion yuan M&A fund for biomedical industry will also be set up.Among them, Chengdu Ruiyuan Semiconductor is mainly engaged in the research and development, design, packaging and sales of power management chips, and one of its main products is DC/DC chips. A-share listed companies include Jingfeng Mingyuan, Fumanwei, Shanghai Beiling and Xidiwei, all of which have certain market share and competitiveness in the DC/DC chip market.
Big move! Two billion M&A and restructuring funds in Shanghai have come to target the chip and pharmaceutical industries.The policy is favorable for surprise attack and seize the opportunity to get on the bus > >A 10 billion yuan M&A fund for biomedical industry will also be set up.
Strategy guide 12-13
Strategy guide 12-13
Strategy guide 12-13
Strategy guide 12-13
Strategy guide
Strategy guide